Performing multiple biomarker tests delays initiation of amyloid-targeting treatments.

Alzheimers Dement (Amst) · 2026 · PMC13314552 · PMID 42382036

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

There may be significant bottlenecks in access to MRI in non‐academic settings and countries besides the United States, 39 and therefore it might influence the door‐to‐needle time for ATTs.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.